Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. NEURACEQ (florbétabène (18F))
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

NEURACEQ (florbétabène (18F))

Medicine - Posted on Apr 25 2023
Active substance (DCI)
  • florbétabène (18F)
history (2)
  • 4/4/23

    NEURACEQ (florbetaben 18F) - Alzheimer’s Disease

    First assessment. Key points Favourable opinion on reimbursement for Positron Emission Tomography (PET) imaging in the diagn...
    CAV :
    54321
    icône flèche
  • 1/9/19

    NEURACEQ (florbétabène (18F))

    Intérêt clinique insuffisant pour justifier son remboursement dans la détection des plaques séniles β amyloïdes en raison de...
    icône flèche
Technical information
ATC code
  • V09AX06
Manufacturer
CURIUM PET FRANCE
Presentation

NEURACEQ 300 MBq/mL solution injectable
1 flacon en verre (CIP : 34009 586 825 2 0)

All our publications
    Alzheimer’s disease and mental disorders Central nervous system diseases Drug therapy Geriatrics Medical imaging Neurodegenerative diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
1hfpFuF002xAT02R